Lorediplon
Clinical data
ATC code
  • None
Legal status
Legal status
  • In general: non-regulated
Identifiers
  • N-{2-fluoro-5-[3-(thiophen-2-ylcarbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl}-N-methylacetamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H15FN4O2S
Molar mass394.42 g·mol−1
3D model (JSmol)
  • O=C(c2cnn3c(c1ccc(F)c(N(C(=O)C)C)c1)ccnc23)c4sccc4
  • InChI=1S/C20H15FN4O2S/c1-12(26)24(2)17-10-13(5-6-15(17)21)16-7-8-22-20-14(11-23-25(16)20)19(27)18-4-3-9-28-18/h3-11H,1-2H3 checkY
  • Key:NQPOCLFSADOXBR-UHFFFAOYSA-N checkY
  (verify)

Lorediplon (INN) is a nonbenzodiazepine of the pyrazolopyrimidine family that is being pursued as a treatment for insomnia but has not completed development.[1][2]

See also

References

  1. ↑ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN): Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2): 179.
  2. ↑ Misra AK, Sharma PK (2020). "Sedative and Hypnotic Drugs". In Uddin MS, Rashid M (eds.). Advances in Neuropharmacology: Drugs and Therapeutics. New York: Apple Academic Press. p. 441. ISBN 978-0-429-51589-7.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.